ADVANCED/METASTATIC GASTROESOPHAGEAL ADENOCARCINOMA

Clinical trials for ADVANCED/METASTATIC GASTROESOPHAGEAL ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ADVANCED/METASTATIC GASTROESOPHAGEAL ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for ADVANCED/METASTATIC GASTROESOPHAGEAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Major trial aims to extend lives in advanced stomach cancer

Disease control Ongoing

This large, late-stage study is testing whether adding two newer drugs (lenvatinib and pembrolizumab) to standard chemotherapy works better than chemotherapy alone for people with advanced stomach or esophageal cancer that has spread. The main goal is to see if the three-drug com…

Matched conditions: ADVANCED/METASTATIC GASTROESOPHAGEAL ADENOCARCINOMA

Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

ADVANCED/METASTATIC GASTROESOPHAGEAL ADENOCARCINOMA

Get alerted when new ADVANCED/METASTATIC GASTROESOPHAGEAL ADENOCARCINOMA trials appear

Major trial aims to extend lives in advanced stomach cancer